ALKERMES reported $23.52M in EBITDA for its fourth fiscal quarter of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Ebitda Change
Abbvie ABBV:US $ 7127M 482M
Acadia Pharmaceuticals ACAD:US $ -112.5M 68.38M
Acorda Therapeutics ACOR:US $ -4.97M 3.28M
Amgen AMGN:US $ 3341M 185M
Biogen BIIB:US $ 674.7M 20.2M
Biomarin Pharmaceutical BMRN:US $ 56.67M 96.56M
Bristol Myers Squibb BMY:US $ 5772M 404M
Coherus Biosciences CHRS:US $ -80.12M 41.48M
Eli Lilly And LLY:US $ 3005.6M 161.6M
Gilead Sciences GILD:US $ 3422M 1947M
H. Lundbeck A/S LUN:DC 1.29B 850M
Heron Therapeutics HRTX:US $ -62.2M 9.46M
Horizon Pharma HZNP:US $ 291.56M 100.61M
Intra Cellular Therapies ITCI:US $ -72.49M 13.37M
IONIS PHARMACEUT IONS:US $ -53.21M 278.25M
JAZZ PHA JAZZ:US $ 267.26M 90.66M
Marinus Pharmaceuticals MRNS:US $ -16.63M 10.4M
Merk MRK:US $ 6179M 492M
Minerva Neurosciences NERV:US $ -7.99M 13.39M
Nektar Therapeutics NKTR:US $ -109.47M 0.5M
Otsuka Holdings 4578:JP Y 64360M 43875M
Regeneron Pharmaceuticals REGN:US $ 1360.9M 1353.3M
Revance Therapeutics RVNC:US $ -56.84M 0.66M
Teva Pharmaceutical Industries TEVA:US $ 1112M 176M
Vertex Pharmaceuticals VRTX:US $ 1069.3M 159.74M